Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Vaccines

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 24 articles: HTML format

Single Articles

November 2021
1. MARTIN CA, Marshall C, Patel P, Goss C, et al
   SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
   PLoS Med. 2021;18:e1003823.
   PubMed     Abstract available
   
   
   
2. BHANU C, Gopal DP, Walters K, Chaudhry UAR, et al
   Vaccination uptake amongst older adults from minority ethnic backgrounds: A systematic review.
   PLoS Med. 2021;18:e1003826.
   PubMed     Abstract available
   
   
   October 2021
3. PEARSON CAB, Bozzani F, Procter SR, Davies NG, et al
   COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
   PLoS Med. 2021;18:e1003815.
   PubMed     Abstract available
   
   
   
4. FORMICA N, Mallory R, Albert G, Robinson M, et al
   Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
   PLoS Med. 2021;18:e1003769.
   PubMed     Abstract available
   
   
   
5. ISANAKA S, Garba S, Plikaytis B, McNeal MM, et al
   Correction: Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial.
   PLoS Med. 2021;18:e1003776.
   PubMed     Abstract available
   
   
   
6. BARRY H, Mutua G, Kibuuka H, Anywaine Z, et al
   Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
   PLoS Med. 2021;18:e1003813.
   PubMed     Abstract available
   
   
   
7. GENG EH, Reid MJA, Goosby E, Abdool-Karim Q, et al
   COVID-19 and global equity for health: The good, the bad, and the wicked.
   PLoS Med. 2021;18:e1003797.
   PubMed     Abstract available
   
   
   September 2021
8. FIGUEROA JP, Hotez PJ, Batista C, Ben Amor Y, et al
   Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
   PLoS Med. 2021;18:e1003772.
   PubMed     Abstract available
   
   
   
9. KROGSGAARD LW, Petersen I, Plana-Ripoll O, Bech BH, et al
   Infections in temporal proximity to HPV vaccination and adverse effects following vaccination in Denmark: A nationwide register-based cohort study and case-crossover analysis.
   PLoS Med. 2021;18:e1003768.
   PubMed     Abstract available
   
   
   
10. NAGATA JM, Epstein A, Ganson KT, Benmarhnia T, et al
    Drought and child vaccination coverage in 22 countries in sub-Saharan Africa: A retrospective analysis of national survey data from 2011 to 2019.
    PLoS Med. 2021;18:e1003678.
    PubMed     Abstract available
    
    
    August 2021
11. CHAN J, Gidding HF, Blyth CC, Fathima P, et al
    Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study.
    PLoS Med. 2021;18:e1003733.
    PubMed     Abstract available
    
    
    
12. ISANAKA S, Garba S, Plikaytis B, Malone McNeal M, et al
    Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial.
    PLoS Med. 2021;18:e1003720.
    PubMed     Abstract available
    
    
    
13. BINES JE
    Investigating barriers to the protective efficacy provided by rotavirus vaccines in African infants.
    PLoS Med. 2021;18:e1003721.
    PubMed     Abstract available
    
    
    July 2021
14. ISANAKA S, Langendorf C, McNeal MM, Meyer N, et al
    Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.
    PLoS Med. 2021;18:e1003655.
    PubMed     Abstract available
    
    
    June 2021
15. GRAY P, Kann H, Pimenoff VN, Eriksson T, et al
    Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
    PLoS Med. 2021;18:e1003588.
    PubMed     Abstract available
    
    
    
16. MAO W, Ogbuoji O, Watkins D, Bharali I, et al
    Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.
    PLoS Med. 2021;18:e1003675.
    PubMed     Abstract available
    
    
    May 2021
17. GOLDMAN M, Hermans C
    Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.
    PLoS Med. 2021;18:e1003648.
    PubMed     Abstract available
    
    
    April 2021
18. KRISHNAN A, Dar L, Saha S, Narayan VV, et al
    Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    PLoS Med. 2021;18:e1003609.
    PubMed     Abstract available
    
    
    March 2021
19. KIM JJ, Simms KT, Killen J, Smith MA, et al
    Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.
    PLoS Med. 2021;18:e1003534.
    PubMed     Abstract available
    
    
    February 2021
20. JEAN K, Raad H, Gaythorpe KAM, Hamlet A, et al
    Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa: A population-level self-controlled case series study.
    PLoS Med. 2021;18:e1003523.
    PubMed     Abstract available
    
    
    
21. KLEYNHANS J, Tempia S, Shioda K, von Gottberg A, et al
    Estimated impact of the pneumococcal conjugate vaccine on pneumonia mortality in South Africa, 1999 through 2016: An ecological modelling study.
    PLoS Med. 2021;18:e1003537.
    PubMed     Abstract available
    
    
    November 2020
22. HOGAN AB, Winskill P, Ghani AC
    Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
    PLoS Med. 2020;17:e1003377.
    PubMed     Abstract available
    
    
    October 2020
23. LAWRENCE H, Pick H, Baskaran V, Daniel P, et al
    Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study.
    PLoS Med. 2020;17:e1003326.
    PubMed     Abstract available
    
    
    
24. BAUMGAERTNER B, Ridenhour BJ, Justwan F, Carlisle JE, et al
    Risk of disease and willingness to vaccinate in the United States: A population-based survey.
    PLoS Med. 2020;17:e1003354.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: